Inovio Pharmaceuticals (INO) Minority Interest (2010 - 2020)

Inovio Pharmaceuticals has disclosed Minority Interest across 11 years of filings, most recently posting $96269.0 for Q3 2020.

• In Q3 2020, Minority Interest fell 96.03% year-over-year to $96269.0; the TTM figure through Sep 2020 stood at $96269.0 (down 96.03% YoY), while the FY2019 annual figure was $2.0 million, up 1946.1% from the prior year.
• Minority Interest came in at $96269.0 for Q3 2020 at Inovio Pharmaceuticals, roughly flat from $96269.0 in the prior quarter.
• In the past five years, Minority Interest ranged from a high of $3.5 million in Q1 2020 to a low of $96269.0 in Q2 2016.
• Average Minority Interest over 5 years is $807336.1, with a median of $96269.0 recorded in 2016.
• Year-over-year, Minority Interest jumped 3075.24% in 2019 and tumbled 96.64% in 2020.
• Over 5 years, Minority Interest stood at $96269.0 in 2016, then changed by 0.0% to $96269.0 in 2017, then changed by 0.0% to $96269.0 in 2018, then soared by 1946.1% to $2.0 million in 2019, then sank by 95.11% to $96269.0 in 2020.
• Per Business Quant data, the three most recent Minority Interest figures were $96269.0 in Q3 2020, $96269.0 in Q2 2020, and $3.5 million in Q1 2020.